Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers

BACKGROUND: Colorectal cancer (CRC) is a heterogeneous disease with distinct clinical subsets based on underlying genetic and epigenetic changes. DNA hypermethylation yields a unique CRC subset with a distinct phenotype and clinical behaviour, but this oncogenic pathway is not fully characterised. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jennifer, Zhou, Wenchao, Sakre, Nneha, DeVecchio, Jennifer, Ferrandon, Sylvain, Ting, Angela H., Bao, Shideng, Bissett, Ian, Church, James, Kalady, Matthew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251029/
https://www.ncbi.nlm.nih.gov/pubmed/30318507
http://dx.doi.org/10.1038/s41416-018-0249-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251029/
https://www.ncbi.nlm.nih.gov/pubmed/30318507
http://dx.doi.org/10.1038/s41416-018-0249-9

Ejemplares similares